Apotea AB (publ) (CHIX:APOTES) Other Long Term Assets: kr5 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:APOTES Apotea AB (publ) CHIX:APOTES
18 GF Score
Price kr65.20
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) Other Long Term Assets?

Apotea AB (publ) CHIX:APOTES 18 Other Long Term Assets is kr5 Mil as of Jun. 2026. GuruFocus rates CHIX:APOTES with a GF Score™ of 18/100. The stock has 1 warning sign investors should review.

Apotea AB (publ)'s other long-term assets for the quarter that ended in Jun. 2026 was kr5 Mil.

Apotea AB (publ)'s quarterly other long-term assets increased from Dec. 2025 (kr5 Mil) to Mar. 2026 (kr5 Mil) and increased from Mar. 2026 (kr5 Mil) to Jun. 2026 (kr5 Mil).

Apotea AB (publ)'s annual other long-term assets increased from Dec. 2023 (kr8 Mil) to Dec. 2024 (kr9 Mil) but then declined from Dec. 2024 (kr9 Mil) to Dec. 2025 (kr5 Mil).

Apotea AB (publ) Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Apotea AB (publ)'s Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apotea AB (publ) Other Long Term Assets Chart

Apotea AB (publ) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Long Term Assets
19.00 7.20 7.90 9.30 4.90

Apotea AB (publ) Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.30 4.50 4.90 4.90 5.10
CHIX:APOTES
18GF Score
Apotea AB (publ) CHIX:APOTES
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apotea AB (publ) Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of kr5 Mil mean?
Apotea AB (publ) (CHIX:APOTES) has a Other Long Term Assets of kr5 Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Apotea AB (publ) and its competitors.
Is Apotea AB (publ)'s Other Long Term Assets too high?
Apotea AB (publ)'s current Other Long Term Assets is kr5 Mil. Overall, Apotea AB (publ) has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Apotea AB (publ)'s Other Long Term Assets compare to competitors?
Apotea AB (publ)'s Other Long Term Assets of kr5 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Healthcare Providers & Services company?
A good Other Long Term Assets depends on the Healthcare Providers & Services industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Apotea AB (publ) and its competitors. Apotea AB (publ)'s current Other Long Term Assets is kr5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apotea AB (publ) stock overvalued right now?
Apotea AB (publ) (CHIX:APOTES) has a current Other Long Term Assets of kr5 Mil. The current Other Long Term Assets is kr5 Mil. Apotea AB (publ)'s overall GF Score™ is 18/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Apotea AB (publ) (CHIX:APOTES), the current Other Long Term Assets is kr5 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apotea AB (publ) Business Description

Other Exchanges APOTEA:SwedenV30:Germany
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
18GF Score

Get the complete analysis for CHIX:APOTES

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr65.20
Price